Wednesday, January 30, 2019 7:25:36 PM
@7:54
"Now I want to emphasize, we don't sell endoscopes. Like the company you've all heard of Olympus is a big German company that sells endoscopes, that's not what we do. We sell our equipment and we adapt to all of the different endoscopes that are on the market."
@ 8:33
"I'm not going to say simple, but the heavy lifting is done. We can adapt the product to adapt to other flourecent type imaging agents. In the simplest of language, the neurology, bladder cancer market is worth potential of about 400M. The minute we move into the abdominal cavity we've elevated ourselves another 400M and we're competing in a 800M market.
Worth mentioning, we know, we've already published a paper on this on cheap bile ducts that we can do this.
Our intellectual property, we have a very strong foundation. It's really important to own your IP. We're really tied on this. We've spent a lot a time on this. We have three issued foundation patents. We're well protected and with the devices that I'm showing you now and the alterations we've made since we started this company, we continue to put in continuation of parts and new patents. So we think we're very very well protected in this area."
@9:52
"We're not going to try to do anything too fancy. We want to get the product on to the market. We're predicting somewheres in the neighborhood of...12 Months and we'll get ourselves on to the market."
- Jim Hutchens, CEO @ Imagin Medical Inc.
See Noblecon 2019 Video Presentation @ Imagin Medical Inc.
/////AMG
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM